SEC Form 4 research
| Issuer | Lexeo Therapeutics, Inc. |
|---|---|
| Tickers | LXEO |
| Reporting owners | 29 |
| Officers and directors | 7 |
| Last public filing | 2026-09-28 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-28 | 2026-09-24 | Tamayo Louis Edward | A | 54,750 | $0 | Not reported |
| 2026-09-28 | 2026-09-14 | Bhalla Narinder Pal | A | 2,714 | $3.58 | Not reported |
| 2026-09-28 | 2026-09-24 | Bhalla Narinder Pal | A | 54,750 | $0 | Not reported |
| 2026-09-28 | 2026-09-14 | Otero Jose Manuel | A | 2,110 | $2.64 | Not reported |
| 2026-09-28 | 2026-09-24 | Otero Jose Manuel | A | 54,750 | $0 | Not reported |
| 2026-09-28 | 2026-09-14 | Townsend Richard Nolan | A | 2,306 | $2.64 | Not reported |
| 2026-09-28 | 2026-09-24 | Townsend Richard Nolan | A | 145,500 | $0 | Not reported |
| 2026-08-19 | 2026-08-18 | Tamayo Louis Edward | S | 4,117 | $4.91 | Not reported |
| 2026-08-19 | 2026-08-18 | Otero Jose Manuel | S | 1,304 | $4.96 | Not reported |
| 2026-08-19 | 2026-08-18 | Townsend Richard Nolan | S | 3,345 | $4.95 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.